Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.95B | 1.82B | 1.86B | 1.81B | 1.86B | Gross Profit |
1.73B | 754.10M | 884.30M | 874.30M | 908.40M | EBIT |
480.20M | 441.40M | 641.50M | 641.00M | 688.00M | EBITDA |
988.60M | 865.00M | 1.06B | 1.06B | 1.17B | Net Income Common Stockholders |
126.90M | 204.90M | -56.80M | 453.40M | 106.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.40B | 340.40M | 240.90M | 744.10M | 528.10M | Total Assets |
15.65B | 14.53B | 14.44B | 14.18B | 14.04B | Total Debt |
10.00B | 8.44B | 7.98B | 8.45B | 8.36B | Net Debt |
8.58B | 8.43B | 7.74B | 7.71B | 7.83B | Total Liabilities |
13.60B | 12.02B | 11.48B | 11.15B | 11.08B | Stockholders Equity |
2.06B | 2.51B | 2.96B | 3.03B | 2.96B |
Cash Flow | Free Cash Flow | |||
-19.00M | 93.50M | 305.90M | 221.80M | 135.20M | Operating Cash Flow |
745.10M | 787.50M | 934.40M | 865.80M | 815.20M | Investing Cash Flow |
-731.40M | -593.40M | -639.70M | -555.70M | -598.80M | Financing Cash Flow |
1.04B | -85.00M | -809.70M | -89.70M | -27.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $12.48B | 7.03 | 28.81% | 1.16% | 41.72% | 195.04% | |
77 Outperform | $2.99B | 15.47 | 12.46% | 2.26% | 30.48% | 267.73% | |
74 Outperform | $28.49B | 27.11 | 10.44% | 2.09% | 10.63% | 10.38% | |
71 Outperform | $10.85B | 18.15 | 9.84% | 3.26% | 1.57% | 16.50% | |
69 Neutral | $3.01B | 24.70 | 14.01% | 2.33% | -0.04% | -5.82% | |
66 Neutral | $9.52B | 65.66 | 5.51% | 4.21% | 12.20% | ― | |
65 Neutral | $11.90B | 15.77 | 6.20% | 4.52% | 5.53% | -8.93% |